In breast carcinoma, localization of eIF4E protein overexpression was mainly cytoplasmic in the cancer cells, but not in the adjacent normal-looking ductal epithelial cells and stromal elements.
Future preclinical work is now underway in order to further develop techniques of non-palpable breast lesion localization using ferromagnetic clip technology loaded with MNPs and handheld magnetometers in order to directly aid the surgeon intraoperatively to excise these lesions using this novel technique.
Imaging techniques that improve breast cancer detection, localization, and evaluation of therapy would be a major breakthrough in combating the disease.
We will be able to control these outcomes for clinical factors such as estimated tumor size, known multi-centric disease, breast imaging, anesthesia, localization technique, neo-adjuvant treatment, and detailed tumor characteristics.
However, primary localization (breast, prostate, head and neck, rectum, or lung) and type of treatment received (radiotherapy and/or chemotherapy) were included into two separate models due to the strong colinearity between these two variables.
Table 2 summarizes the relationship between N-cadherin expression and the clinicopathological features of the breast cancers: membrane localization of N-cadherin in tumors significantly correlated with smaller tumor size (5 out of 36 cases pT1 vs. 1 out of 47 cases pT2, P = 0.04); in contrast, nuclear expression of N-cadherin was observed primarily in poorly differentiated tumors.
The following variables were considered: standard error of log HR, tumour localization (breast, stomach, lung, colon, ovary, corpus, skin yes/no), randomization (yes/no), matched-pair comparison (yes/no) - due to the fact that all matched-pair studies were from the same source.
Herein, we demonstrate hornerin expression and localization in breast tissue and breast cancer, as well as changes in regulation during cell apoptotic/necrotic events.
Another important difference was found with respect to the genotype distribution as well as the allelic frequency comparing the tumor localization (right breast vs. left breast) for the RANK SNP rs35211496.
Therefore we decided to investigate the effect of maspin localization on breast cancer with reference to clinical data from breast cancer specimens from patients.
